Lv42
660 积分 2023-02-17 加入
Measurable residual disease monitoring in AML: Prospects for therapeutic decision‐making and new drug development
1天前
已完结
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel
3个月前
已完结
[Expert consensus on the test development and preliminary implementation of whole genome sequencing for fetal structural abnormalities]
3个月前
已完结
Single-cell immune landscape of measurable residual disease in acute myeloid leukemia
3个月前
已完结
[Expert consensus on the test development and preliminary implementation of whole genome sequencing for fetal structural abnormalities]
4个月前
已完结
[Expert consensus on the test development and preliminary implementation of whole genome sequencing for fetal structural abnormalities]
4个月前
已完结
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
4个月前
已关闭
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
4个月前
已关闭
Clonal Hematopoiesis-Associated Gene Mutations Affect Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation in AML Patients
4个月前
已完结
Atypical CML: diagnosis and treatment
4个月前
已完结
皖公网安备34019202002308
